ASCO 2025 overall survival data bolster IMNN-001’s potential in advanced ovarian cancer, supported by robust translational results at ESMO Results from OVATION 2 Study reinforce IMNN-001 mechanism of ...

Eli Lilly acquires Verve Therapeutics, Inc. for $1B to advance gene-editing therapies like VERVE-102, targeting ASCVD. Click ...

Watching for new technological trends is one of the best ways for keeping up with smart grid innovations, but it’s not easy.

Editas Medicine ( EDIT 12.04%) is a promising clinical-stage company that has captured Wall Street's attention at the ...

For decades, researchers have wondered why some people with risky gene variants go on to develop Parkinson’s disease, while ...

Sarepta’s shares crashed 41% in premarket trading Monday morning to $21.01 after the biotech reported a second death from ...

Brain Tumours, particularly malignant types such as glioblastoma multiforme (GBM), continue to pose a significant clinical ...

Glioblastoma has been deadly and hard to treat, but researchers say they’ve made progress with bivalent CAR T-cell therapy ...

Researchers have developed a lung-targeted nanoparticle delivery system for genetic therapies. In a major step forward for ...

A major cause of hospital-acquired infections, the super bacteria Methicillin-resistant Staphylococcus aureus (MRSA), not ...

Find more information on the Altmetric Attention Score and how the score is calculated. In this study, a novel liver-targeted gene delivery vector was developed by electrostatically coating the ...